Allan R. Brasier, MD

Director, Institute for Translational Sciences
CTSA Principal Investigator
UT Medical Branch at Galveston

Daniel D. Karp, MD

Medical Director, Clinical Translational Research Center
CTSA Principal Investigator
UT MD Anderson Cancer Center


Paula K. Shireman, MD, MS

Scientific Advisor, Clinical Trials Xpress
CTSA Co-Principal Investigator
UT Health Science Center at San Antonio

The Texas Regional CTSA Consortium is a collaborative research network to advance innovative practices in translational science across Texas for the improvement of human health.


  • Proteomics Network Initiative
  • TRCC Health Biobank Consortium
  • Core Laboratory Services and Equipment Sharing Initiative

The TRCC Executive Committee sets the criteria for the selection and prioritization of the CTX portfolio. 

Robert Toto, MD, TRCC Chair

Director, Center for Translational Medicine
CTSA Principal Investigator
UT Southwestern Medical Center

BethLynn Maxwell, PhD, JD
Chief Health Research Officer,

Associate General Counsel

UT System

David D. McPherson, MD

Executive Director, Center for Clinical and Translational Sciences
CTSA Principal Investigator
UT Health Houston

Robert A. Clark, MD

Assistant Vice President for Clinical Research
CTSA Principal Investigator

UT Health Science Center at San Antonio



OUR MISSION
The Texas Regional CTSA Consortium (TRCC) is a regional consortium of the national Clinical and Translational Science Award program. TRCC is a collaborative research network which advances innovative practices in translational science across Texas for the improvement of human health.

OUR GOAL
The goal of the TRCC is to facilitate clinical and translational research and dissemination among the Texas CTSA hubs and other interested Texas and national biomedical research institutions.

OUR MEMBERS
The founding Texas CTSA award institutions include UT Health and UT MD Anderson in Houston, UT Southwestern Medical Center in Dallas, UT Health Science Center in San Antonio and UT Medical Branch in Galveston
.


OUR STRATEGIC MODEL

Collaborate, Encourage, Foster, Advance, Support
       

OUR INITIATIVES

  • Clinical Trials Xpress
  • Statewide Master IRB Reciprocity Agreement
  • Clinical Trial Management System Initiative 
  • Work with the people of Texas to determine health priorities, foster community involvement, trust and participation in research, and implement best practices that improve health.
  • Encourage, support, conduct, and evaluate clinical and translational research across the state of Texas and nationally.
  • Actively support the strategic goals of the National Consortium.
  • Foster the efforts of key function consortia within the TRCC and disseminate the methods for the development and implementation of their best practices to both CTSA and non-CTSA institutions.
  • Advance and improve education to enhance the clinical and translational research workforce through statewide and national collaborations.